PhD Intern – Healthcare

QIMING VENTURE PARTNERS PhD Intern – Healthcare

Beijing / Shanghai / North America

Qiming is seeking outstanding PhD candidates to work directly with the Healthcare investment team as PhD Intern, focusing on Biotech;
Based on your experience, you will learn how to help identify new investment themes and opportunities, while assisting in all aspects of the investment process. The PhD Intern will:

• Work closely with a mentor in evaluation of investments
• Help shape investment themes through industry and market research
• Take other possible short-term assignments related to investment assigned by mentor

• PhD candidate from a top-tier university majoring in molecular biology, biochemistry, medicinal chemistry, pharmacology, medicine, or AI-related fields
• A robust analytical skill set: ability to establish and apply process rigor with attention to details
• A fast learner with strong intellectual curiosity
• Fluent in written and spoken English and Chinese
• A minimum of three months commitment is required

About Qiming Venture Partners

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Currently Qiming Venture Partners manages ten US Dollar funds and six RMB funds with $6.2 billion in AUM capital raised. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.

Since our debut, we have backed over 430 fast-growing and innovative companies. Over 170 companies are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or achieved exit through M&A and other means. There are also over 40 portfolio companies that have achieved unicorn status.

Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), Venus Med Tech (SEHK:2500), Can Sino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), New Horizon Health (SEHK:6606), Sanyou Medical (SHSE:688085), Amoy Dx (SZSE:300685), Berry Genomics (SZSE:000710), Sinocell Tech (SHSE: 688520), WeDoctor Group, and UBTech among many others.

The intern program is part-time and compensated. Please contact HR to submit your resume.